Clinical trial
External Counterpulsation Therapy for Symptomatic and Severe Steno-occlusive Disease of Intracranial Internal Carotid or Middle Cerebral Artery and Impaired Cerebral Vasodilatory Reserve
NCT03921827 is registered in ClinicalTrials.gov with National University of Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- External Counterpulsation Therapy for Symptomatic and Severe Steno-occlusive Disease of Intracranial Internal Carotid or Middle Cerebral Artery and Impaired Cerebral Vasodilatory Reserve
- Lead sponsor
- National University of Singapore
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 8, 2019
- Completion date
- November 30, 2024
- Enrollment
- 130 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.